Table 3.
Treatments | 0D | 1D | 2D | 0D | 1D | 2D | 0D | 1D | 2D | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2016–17 | 0 K | CK | 1.76c | 0.80c | 0.68d | 0.81b | 0.52e | 0.36d | 2.57e | 1.32e | 1.04c |
SP | 2.02b | 0.90c | 1.05bc | 1.01b | 0.84de | 0.81bc | 3.03d | 1.74d | 1.86b | ||
FS | 2.26a | 0.95c | 0.95bc | 0.98b | 0.95bc | 0.71c | 3.24cd | 1.90d | 1.66b | ||
100 K | CK | 2.02b | 1.45b | 0.92cd | 1.28a | 0.72de | 0.78bc | 3.30bc | 2.17c | 1.70b | |
SP | 2.19ab | 2.05a | 1.18ab | 1.45a | 1.11ab | 0.96ab | 3.65a | 3.16b | 2.15a | ||
FS | 2.15ab | 2.15a | 1.29a | 1.34a | 1.28a | 1.04a | 3.50ab | 3.43a | 2.33a | ||
Mean | 2.07A | 1.38B | 1.01C | 1.15A | 0.90B | 0.78C | 3.21A | 2.29B | 1.79C | ||
2017–18 | 0 K | CK | 1.68d | 0.76c | 0.70c | 0.80d | 0.59c | 0.35d | 2.48d | 1.35e | 1.05c |
SP | 1.95c | 0.86c | 0.94b | 1.06c | 0.90b | 0.77c | 3.01c | 1.77d | 1.71b | ||
FS | 2.16a | 0.91c | 0.91b | 0.98c | 0.94b | 0.71c | 3.14bc | 1.86d | 1.62b | ||
100 K | CK | 1.99bc | 1.41b | 0.83bc | 1.27b | 0.71c | 0.80bc | 3.25b | 2.13c | 1.63b | |
SP | 2.16ab | 2.01a | 1.20a | 1.45a | 1.18a | 0.96ab | 3.61a | 3.19b | 2.16a | ||
FS | 2.12abc | 2.11a | 1.24a | 1.38ab | 1.28a | 1.02a | 3.50a | 3.39a | 2.26a | ||
Mean | 2.01A | 1.35B | 0.97C | 1.16A | 0.93B | 0.77C | 3.17A | 2.28B | 1.74C | ||
SOV | Chl a | Chlb | Chl a + b | ||||||||
Year(Y) | Ns | 1 | Ns | Ns | |||||||
Drought(D) | ** | 2 | ** | ** | |||||||
D × Y | Ns | 3 | Ns | Ns | |||||||
Salicylic acid(SA) | ** | 4 | ** | ** | |||||||
Potassium (K) | ** | 5 | ** | ** | |||||||
SA × Y | Ns | 6 | ns | ns | |||||||
D × SA | Ns | 7 | ** | ** | |||||||
K × Y | Ns | 8 | ns | ns | |||||||
D × K | * | 9 | ** | ** | |||||||
SA × K | Ns | 10 | ns | ns | |||||||
SA × K × Y | Ns | 11 | ns | ** | |||||||
D × K × Y | Ns | 12 | ns | ns | |||||||
D × SA × K | ** | 13 | * | ** | |||||||
D × SA × K × Y | Ns | 14 | ns | ns |
ns non significant, ** significant at 1% level of probability, * significant at 5% level of probability.